Lipocine Inc. (LPCN)

CIK 0001535955 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-04) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-10) · 99.1  |  8-K (2026-02-18) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-05) · 99.1
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 8-K (2024-03-07) · 99.1
Q3-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Income (loss)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
401(k) Plan
—
Agreement With Spriaso, Llc
Basis of Presentation
—
Commitments and Contingencies
Contractual Agreements
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Revenue
—
Description of Business
—
Earnings (loss) Per Share
—
Fair Value
—
Income Taxes
Insider Trading Arrangements
Leases
Loan and Security Agreement
Loss Per Share
—
Marketable Investment Securities
Pay Vs Performance Disclosure
Property and Equipment
—
Recent Accounting Pronouncements
Revenue
—
Segment Reporting
Stockholders Equity
Subsequent Events
Summary of Significant Accounting Policies
—